Hatfield Jeffrey S. 4
4 · Vir Biotechnology, Inc. · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Hatfield Jeffrey S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-09+46,500→ 46,500 totalExercise: $29.43Exp: 2030-12-08→ Common Stock (46,500 underlying)
Footnotes (1)
- [F1]1/3 of the shares subject to the stock option vest and become exercisable on December 9, 2021, and the remaining shares vest in 24 equal monthly installments thereafter.